FDA Investigator: Kevin P. Foley
- Kevin P. Foley first started conducting FDA inspections in 2002, with the last inspection in 2016. Over that time, Kevin P. Foley has conducted 148 inspections at 121 companies across 124 sites.
Get Kevin Foley's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Sanofi Pasteur SA, Marcy l'Etoile | 2016
Out-of-stock
Kevin P. Foley
Biologic Form 483
FDA 483 Telesta Therapeutics Inc., Pointe-Claire | 2015
Out-of-stock
Kevin P. Foley
Human Drug Form 483
FDA 483 CSL Behring GmbH, Marburg | 2015
Out-of-stock
Kevin P. Foley
Biologic Form 483
FDA 483 AMPAC Fine Chemicals, LLC, Rancho Cordova | 2012
Out-of-stock
Kevin P. Foley
Human Drug Form 483
FDA 483 FDC Limited, Aurangabad, Maharashtra State | 2012
Out-of-stock
Kevin P. Foley
Human Drug Form 483
FDA 483 Gilead Sciences Inc, Foster City | 2011
Out-of-stock
Kevin P. Foley
Human Drug Form 483
FDA 483 Columbia Cosmetics Manufacturing, Inc., San Leandro | 2011
Out-of-stock
Kevin P. Foley
Foods & Cosmetic Form 483
FDA 483 Apotex Inc., Etobicoke | 2011
Out-of-stock
Kevin P. Foley
Human Drug Form 483
FDA 483 Zhejiang Jianfeng Haizhou Pharma Co., Ltd., Linhai City | 2011
Out-of-stock
Kevin P. Foley
Human Drug Form 483
FDA 483 Yunnan Hande Bio-Tech Co., Ltd., Kunming | 2011
Out-of-stock
Kevin P. Foley
Human Drug Form 483
FDA 483 Mills-Peninsula Health Services and San Mateo Medical Center, Burlingame | 2011
Out-of-stock
Kevin P. Foley
Medical Devices & Rad Health Form 483
FDA 483 Airgas NCN, Santa Rosa | 2011
Out-of-stock
Kevin P. Foley
Human Drug Form 483
FDA 483 Guardian Drug Co. Inc., Dayton | 2011
Out-of-stock
Kevin P. Foley
Human Drug Form 483
FDA 483 Alza Corporation, Vacaville | 2010
Out-of-stock
Kevin P. Foley
Human Drug Form 483
FDA 483 Genentech, Inc., South San Francisco | 2010
Out-of-stock
Kevin P. Foley
Human Drug Form 483
FDA 483 PharmPak, Inc., San Rafael | 2010
Out-of-stock
Kevin P. Foley
Human Drug Form 483
FDA 483 Impax Laboratories, Inc., Hayward | 2010
Out-of-stock
Kevin P. Foley
Human Drug Form 483
FDA 483 Airgas NCN, San Jose | 2010
Out-of-stock
Kevin P. Foley
Human Drug Form 483
FDA 483 Apria Healthcare, Inc, Novato | 2010
Out-of-stock
Kevin P. Foley
Human Drug Form 483
FDA 483 Jeffrey A. Golden, San Francisco | 2010
Out-of-stock
Kevin P. Foley
Human Drug Form 483
FDA 483 PCAS-Nanosyn LLC, Santa Rosa | 2010
Out-of-stock
Kevin P. Foley
Human Drug Form 483
FDA 483 Synthokem Labs Private Ltd., Hyderabad | 2009
Out-of-stock
Kevin P. Foley
Human Drug Form 483
FDA 483 Vitalife Laboratories (a Div. Of Arch Pharmalabs Ltd.), Gurgaon | 2009
Out-of-stock
Kevin P. Foley
Human Drug Form 483
FDA 483 Intas Pharmaceuticals Limited, Ahmedabad City | 2009
Out-of-stock
Kevin P. Foley
Human Drug Form 483
FDA 483 Huatai Biopharm Inc., Deyang | 2009
Out-of-stock
Kevin P. Foley
Human Drug Form 483
FDA 483 Suzhou Amerigen Pharmaceutical, Jiangsu | 2009
Out-of-stock
Kevin P. Foley
Human Drug Form 483
FDA 483 Jilin Shulan Synthetic Pharmaceutical Co. Ltd., Jilinshi | 2009
Out-of-stock
Kevin P. Foley
Human Drug Form 483
FDA 483 Sanofi Chimie, Sisteron | 2009
Out-of-stock
Kevin P. Foley
Human Drug Form 483
Co-Investigators (31)
- Nicole K. Trudel, FDA Investigator
- Donald B. Ertel, FDA Investigator
- Karen D. Phung, FDA Investigator
- Lija V. Fellows, FDA Investigator
- Dandan Wang, FDA Investigator
- Parul M. Patel, FDA Investigator
- Sneha S. Patel, FDA Investigator
- Marie A. Fadden, FDA Investigator
- Karen E. Dorazio, FDA Investigator
- Peter E. Baker, FDA Investigator
- Douglas A. Campbell, FDA Investigator
- Miguel A. Martinez, FDA Investigator
- Katherine Szestypalow, FDA Investigator
- Jeffrey M. Watson, FDA Investigator
- Mei-Chiung J. Huang, FDA Investigator
- Lance M. De Souza, FDA Investigator
- De Souza, Lance M, FDA Investigator
- Jane M. Kreis, FDA Investigator
- Darlene B. Almogela, FDA Investigator
- Carl Lee, FDA Investigator
- Omotunde O. Osunsanmi, FDA Investigator
- Mihaly S. Ligmond, FDA Investigator
- Ralph A. Erickson, FDA Investigator
- Raymond T. Oji, FDA Investigator
- Nicole Yuen, FDA Investigator
- Larkin R. Buckalew, FDA Investigator
- Mary C. Acton, FDA Investigator
- Rebecca E. Sulpacio, FDA Investigator
- Daniel C. Geffin, FDA Investigator
- Ronald P. Boyce, FDA Investigator
- Raymond Souweha, FDA Investigator

